Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus

Stefano Benvegnù1, Paola Roncaglia, Federica Agostini

  • 1Laboratory of Prion Biology, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste.

Physiological Genomics
|March 17, 2011
PubMed

Insights

Silencing cellular prion protein (PrP(C)) may treat prion diseases. Gene expression analysis in PrP(C)-deficient mice showed moderate changes, suggesting this approach is viable without severe brain disruption.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Prion diseases involve the conversion of cellular prion protein (PrP(C)) to a pathogenic form.
  • Mice lacking PrP(C) show resistance to prion infection, suggesting PrP(C) silencing as a potential therapy.
  • The physiological role of PrP(C) is not fully understood, but it's implicated in neuronal functions.

Purpose of the Study:

  • To investigate the impact of PrP(C) absence on the overall gene expression profile in the mouse brain.
  • To assess potential detrimental effects of PrP(C) silencing on brain homeostasis.
  • To evaluate the feasibility of PrP(C) downregulation as a therapeutic strategy for prion diseases.

Main Methods:

  • Microarray analysis of hippocampal RNA from newborn and adult wild-type and PrP(C)-deficient (Prnp(0/0)) mice.
  • Comparison of gene expression datasets to identify commonly and uniquely deregulated genes.
  • Analysis of affected biological pathways, including cell signaling, development, and synaptic transmission.

Main Results:

  • PrP(C) absence moderately altered the gene expression profile in mouse brains.
  • Key affected pathways included cell signaling, nervous system development, and synaptic transmission.
  • No dramatic alterations in gene expression were observed between young and adult PrP(C)-deficient mice.

Conclusions:

  • PrP(C) deficiency leads to moderate, not drastic, changes in gene expression.
  • The findings support the potential of silencing endogenous PrP(C) as a therapeutic approach for prion diseases.
  • Further research into PrP(C) function and the consequences of its silencing is warranted.

Related Concept Videos